Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 14, 2012; 18(26): 3400-3408
Published online Jul 14, 2012. doi: 10.3748/wjg.v18.i26.3400
Published online Jul 14, 2012. doi: 10.3748/wjg.v18.i26.3400
Indication | Group A standard colonoscopy first | Group B Third Eye colonoscopy first | Relative risk2 (95% CI) | P |
All Indications3 | 49/173 = 0.283 | 26/176 = 0.148 | 1.92 (1.25-2.94) | 0.029 |
Screening | 19/91 = 0.209 | 16/85 = 0.188 | 1.11 (0.62-2.04) | 0.815 |
Surveillance | 20/36 = 0.556 | 9/51 = 0.176 | 3.15 (1.63-6.10) | 0.014 |
Diagnostic | 10/44 = 0.227 | 1/38 = 0.026 | 8.64 (1.16-64.41) | 0.039 |
Surveillance + diagnostic | 30/80 = 0.375 | 10/89 = 0.112 | 3.34 (1.74-6.39) | 0.003 |
- Citation: Siersema PD, Rastogi A, Leufkens AM, Akerman PA, Azzouzi K, Rothstein RI, Vleggaar FP, Repici A, Rando G, Okolo PI, Dewit O, Ignjatovic A, Odstrcil E, East J, Deprez PH, Saunders BP, Kalloo AN, Creel B, Singh V, Lennon AM, DeMarco DC. Retrograde-viewing device improves adenoma detection rate in colonoscopies for surveillance and diagnostic workup. World J Gastroenterol 2012; 18(26): 3400-3408
- URL: https://www.wjgnet.com/1007-9327/full/v18/i26/3400.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i26.3400